Last Updated: December 16, 2021 Last Updated: December 16, 2021 Colchicine is an anti-inflammatory drug that is used to treat a variety of conditions, including gout, recurrent pericarditis, and familial Mediterranean fever.1 Recently, […]
Does COVID-19 Cause Hypertension?
Authors: Mahmut Akpek, MD December 10, 2021 Research Article https://doi.org/10.1177/00033197211053903 Abstract The coronavirus disease 2019 (COVID-19) outbreak remains a major public health challenge worldwide. The present study investigated the effect of COVID-19 […]
Acute Kidney Injury in COVID-19
Authors: Marta Głowacka, Sara Lipka, Ewelina Młynarska,*Beata Franczyk, and Jacek RyszHajime Nagasu, Academic Editor Int J Mol Sci. 2021 Aug; 22(15): 8081.Published online 2021 Jul 28. doi: 10.3390/ijms22158081 PMCID: PMC8347536PMID: 34360866 Abstract COVID-19 is mainly considered a respiratory illness, […]
Five months post-covid, Nicole Murphy’s heart rate is still doing strange things
Authors: Ariana Eunjung Cha February 21, 2022 Five months after being infected with the coronavirus, Nicole Murphy’s pulse rate is going berserk. Normally in the 70s, which is ideal, it […]
Mystery of the missing workers? Long COVID a big piece of the puzzle
Authors: Michael E. Kanell, The Atlanta Journal-Constitution Feb 19, 2022 She suffered cardiac arrest twice and was in the hospital for three months, then came home to more than a […]
Long COVID Could Be Linked to the Effects of SARS-CoV-2 on the Vagus Nerve
Authors: EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES FEBRUARY 11, 2022 New research to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2022, Lisbon, April […]
Management of urticaria in COVID-19 patients: A systematic review
Authors: Eyad Abuelgasim,Ann Christine Modaragamage Dona,Rajan Singh Sondh,Amer Harky First published: 28 September 2020 https://doi.org/10.1111/dth.14328 Abstract The global pandemic COVID-19 has resulted in significant global morbidity, mortality and increased healthcare demands. […]
Famotidine clinical trial shows COVID-19 symptom reduction
Authors: Dagnia Zeidlickis, Vice President, Communications | zeidlick@cshl.edu | 516-367-8455 A high dose of famotidine, commonly known as Pepcid®, was found to have beneficial effects in adult patients with coronavirus disease 2019 (COVID-19), according […]
Heart-disease risk soars after COVID — even with a mild case
Authors: Saima May Sidik 10 February 2022 Massive study shows a long-term, substantial rise in risk of cardiovascular disease, including heart attack and stroke, after a SARS-CoV-2 infection. Even a […]
